Home
>
National Drug Code (NDC)
>
BUMINATE
BUMINATE - 0944-0491-01 - (Albumin Human)
Drug Information of BUMINATE
| Product NDC: | 0944-0491 |
| Proprietary Name: | BUMINATE |
| Non Proprietary Name: | Albumin Human |
| Active Ingredient(s): | .05 g/mL & nbsp; Albumin Human |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of BUMINATE
| Product NDC: | 0944-0491 |
| Labeler Name: | Baxter Healthcare Corporation |
| Product Type: | PLASMA DERIVATIVE |
| FDA Application Number: | BLA101452 |
| Marketing Category: | BLA |
| Start Marketing Date: | 19550616 |
Package Information of BUMINATE
| Package NDC: | 0944-0491-01 |
| Package Description: | 250 mL in 1 BOTTLE, GLASS (0944-0491-01) |
NDC Information of BUMINATE
| NDC Code | 0944-0491-01 |
| Proprietary Name | BUMINATE |
| Package Description | 250 mL in 1 BOTTLE, GLASS (0944-0491-01) |
| Product NDC | 0944-0491 |
| Product Type Name | PLASMA DERIVATIVE |
| Non Proprietary Name | Albumin Human |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19550616 |
| Marketing Category Name | BLA |
| Labeler Name | Baxter Healthcare Corporation |
| Substance Name | ALBUMIN (HUMAN) |
| Strength Number | .05 |
| Strength Unit | g/mL |
| Pharmaceutical Classes | Human Serum Albumin [EPC],Increased Intravascular Volume [PE],Increased Oncotic Pressure [PE],Osmotic Activity [MoA],Serum Albumin [Chemical/Ingredient] |
